Cargando…
Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives
Lung cancer (LC) is the leading cause of cancer death worldwide. Tobacco smoke is the most frequent risk factor etiologically associated with LC, although exposures to other environmental factors such as arsenic, radon or asbestos are also involved. Additionally, the involvement of some viral infect...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878590/ https://www.ncbi.nlm.nih.gov/pubmed/35215076 http://dx.doi.org/10.3390/pathogens11020132 |
_version_ | 1784658695230062592 |
---|---|
author | Osorio, Julio C. Blanco, Rancés Corvalán, Alejandro H. Muñoz, Juan P. Calaf, Gloria M. Aguayo, Francisco |
author_facet | Osorio, Julio C. Blanco, Rancés Corvalán, Alejandro H. Muñoz, Juan P. Calaf, Gloria M. Aguayo, Francisco |
author_sort | Osorio, Julio C. |
collection | PubMed |
description | Lung cancer (LC) is the leading cause of cancer death worldwide. Tobacco smoke is the most frequent risk factor etiologically associated with LC, although exposures to other environmental factors such as arsenic, radon or asbestos are also involved. Additionally, the involvement of some viral infections such as high-risk human papillomaviruses (HR-HPVs), Merkel cell polyomavirus (MCPyV), Jaagsiekte Sheep Retrovirus (JSRV), John Cunningham Virus (JCV), and Epstein–Barr virus (EBV) has been suggested in LC, though an etiological relationship has not yet been established. EBV is a ubiquitous gamma herpesvirus causing persistent infections and some lymphoid and epithelial tumors. Since EBV is heterogeneously detected in LCs from different parts of the world, in this review we address the epidemiological and experimental evidence of a potential role of EBV. Considering this evidence, we propose mechanisms potentially involved in EBV-associated lung carcinogenesis. Additional studies are warranted to dissect the role of EBV in this very frequent malignancy. |
format | Online Article Text |
id | pubmed-8878590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88785902022-02-26 Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives Osorio, Julio C. Blanco, Rancés Corvalán, Alejandro H. Muñoz, Juan P. Calaf, Gloria M. Aguayo, Francisco Pathogens Review Lung cancer (LC) is the leading cause of cancer death worldwide. Tobacco smoke is the most frequent risk factor etiologically associated with LC, although exposures to other environmental factors such as arsenic, radon or asbestos are also involved. Additionally, the involvement of some viral infections such as high-risk human papillomaviruses (HR-HPVs), Merkel cell polyomavirus (MCPyV), Jaagsiekte Sheep Retrovirus (JSRV), John Cunningham Virus (JCV), and Epstein–Barr virus (EBV) has been suggested in LC, though an etiological relationship has not yet been established. EBV is a ubiquitous gamma herpesvirus causing persistent infections and some lymphoid and epithelial tumors. Since EBV is heterogeneously detected in LCs from different parts of the world, in this review we address the epidemiological and experimental evidence of a potential role of EBV. Considering this evidence, we propose mechanisms potentially involved in EBV-associated lung carcinogenesis. Additional studies are warranted to dissect the role of EBV in this very frequent malignancy. MDPI 2022-01-21 /pmc/articles/PMC8878590/ /pubmed/35215076 http://dx.doi.org/10.3390/pathogens11020132 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Osorio, Julio C. Blanco, Rancés Corvalán, Alejandro H. Muñoz, Juan P. Calaf, Gloria M. Aguayo, Francisco Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives |
title | Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives |
title_full | Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives |
title_fullStr | Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives |
title_full_unstemmed | Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives |
title_short | Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives |
title_sort | epstein–barr virus infection in lung cancer: insights and perspectives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878590/ https://www.ncbi.nlm.nih.gov/pubmed/35215076 http://dx.doi.org/10.3390/pathogens11020132 |
work_keys_str_mv | AT osoriojulioc epsteinbarrvirusinfectioninlungcancerinsightsandperspectives AT blancorances epsteinbarrvirusinfectioninlungcancerinsightsandperspectives AT corvalanalejandroh epsteinbarrvirusinfectioninlungcancerinsightsandperspectives AT munozjuanp epsteinbarrvirusinfectioninlungcancerinsightsandperspectives AT calafgloriam epsteinbarrvirusinfectioninlungcancerinsightsandperspectives AT aguayofrancisco epsteinbarrvirusinfectioninlungcancerinsightsandperspectives |